🔗 Permalink

Inventor profile of:

Erkan Baloglu

City:

Stoneham, Massachusetts

Country:

United States

Published Applications:

45

Last publication date:

2026-03-26

Top Assignees for applications by Erkan Baloglu

The entities that hold a legal rights for patent applications filed by inventor Baloglu Erkan:

Karyopharm Therapeutics Inc. 19 Newton, MA United States
BIOGEN MA INC. 6 Cambridge, MA United States
Immunogen, Inc. 3 Cambridge, MA United States
ImmunoGen, INC. 2 Waltham, MA United States
AVENTIS PHARMA S.A. 2 Antony, France
Karyopharm Therapeutics Inc. 2 Natick, MA United States
Tempero Pharmaceuticals, Inc. 1 Cambridge, MA United States
Karopharm Therapeutics Inc. 1 Newton, MA United States
INOTEK PHARMACEUTICALS CORPORATION 1 Beverly, MA United States

Recent patent applications by Baloglu Erkan

Erkan Baloglu from Stoneham, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-03-26

US20260085064A1

Chemistry; metallurgy

SUBSTITUTED BENZOFURANYL AND BENZOXAZOLYL COMPOUNDS AND USES THEREOF

#2 | 2025-02-20

US20250059158A1

Chemistry; metallurgy

NUCLEAR TRANSPORT MODULATORS AND USES THEREOF

#3 | 2024-08-29

US20240287041A1

Chemistry; metallurgy

METHODS OF SYNTHESIS OF HETEROARYL DERIVATIVES OF TRIAZOLYL ACRYLAMIDES AND CRYSTALLINE FORMS

#4 | 2022-06-09

US20220177445A1

Chemistry; metallurgy

Nuclear transport modulators and uses thereof

#5 | 2021-12-30

US20210403459A1

Chemistry; metallurgy

SUBSTITUTED BENZOFURANYL AND BENZOXAZOLYL COMPOUNDS AND USES THEREOF

#6 | 2021-10-14

US20210315897A1

Human necessities

Combination of XPO1 inhibitors and second agents for the treatment of prostate cancer

#7 | 2021-08-19

US20210251968A1

Human necessities

Nuclear transport modulators and uses thereof

#8 | 2020-07-23

US20200230110A1

Human necessities

Nuclear transport modulators and uses thereof

#9 | 2020-06-25

US20200199099A1

Chemistry; metallurgy

Nuclear transport modulators and uses thereof

#10 | 2020-04-02

US20200102292A1

Chemistry; metallurgy

Substituted benzofuranyl and benzoxazolyl compounds and uses thereof

#11 | 2020-02-06

US20200038373A1

Human necessities

Nuclear transport modulators and uses thereof

#12 | 2019-07-18

US20190218207A1

Chemistry; metallurgy

3-(Pyridin-3-yl)-Acrylamide and N-(Pyridin-3-yl)-Acrylamide Derivatives and Their Use as PAK or NAMPT Modulators

#13 | 2019-05-30

US20190160063A1

Human necessities

Nuclear transport modulators and uses thereof

#14 | 2019-01-17

US20190016710A1

Chemistry; metallurgy

Multicyclic compounds and uses thereof

#15 | 2019-01-17

US20190016690A1

Chemistry; metallurgy

Nuclear transport modulators and uses thereof

#16 | 2019-01-10

US20190008833A1

Human necessities

Nuclear transport modulators and uses thereof

#17 | 2019-01-03

US20190002448A1

Chemistry; metallurgy

SUBSTITUTED BENZOFURANYL AND BENZOXAZOLYL COMPOUNDS AND USES THEREOF

#18 | 2018-11-08

US20180319779A1

Chemistry; metallurgy

Substituted benzofuranyl and benzoxazolyl compounds and uses thereof

#19 | 2018-10-11

US20180289675A1

Human necessities

Nuclear transport modulators and uses thereof

#20 | 2018-08-30

US20180244660A1

Chemistry; metallurgy

CYCLOPROPYLDERIVATIVES AND THEIR USE AS KINASE INHIBITORS

#21 | 2018-08-23

US20180235948A1

Human necessities

(S,E)-3-(6-aminopyridin-3-yl)-N-((5-(4-(3-fluoro-3-methylpyrrolidine-1-carbonyl)phenyl-7-(4-fluorophenyl)benzofuran-2-yl)methyl)acrylamide for the treatment of cancer

#22 | 2018-06-07

US20180155317A1

Chemistry; metallurgy

Nuclear transport modulators and uses thereof

#23 | 2017-12-28

US20170369470A1

Chemistry; metallurgy

Cyclic Compounds and Uses Thereof

#24 | 2017-11-09

US20170319551A1

Human necessities

Nuclear transport modulators and uses thereof

#25 | 2017-04-06

US20170096417A1

Chemistry; metallurgy

Multicyclic compounds and methods of using same

#26 | 2016-12-22

US20160368904A1

Chemistry; metallurgy

Substituted benzofuranyl and benzoxazolyl compounds and uses thereof

#27 | 2016-12-08

US20160354347A1

Human necessities

Nuclear transport modulators and uses thereof

#28 | 2016-10-20

US20160304500A1

Chemistry; metallurgy

Methods of promoting wound healing using CRM1 inhibitors

#29 | 2016-08-04

US20160221994A1

Chemistry; metallurgy

Substituted 2,3-dihydrobenzofuranyl compounds and uses thereof

#30 | 2016-06-02

US20160152596A1

Chemistry; metallurgy

Nuclear transport modulators and uses thereof

#31 | 2016-05-26

US20160145246A1

Chemistry; metallurgy

Nuclear transport modulators and uses thereof

#32 | 2015-04-23

US20150111893A1

Chemistry; metallurgy

Nuclear transport modulators and uses thereof

#33 | 2014-10-23

US20140315881A1

Chemistry; metallurgy

COMPOUNDS AND METHODS

#34 | 2014-09-11

US20140256740A1

Chemistry; metallurgy

COMPOUNDS AND METHODS

#35 | 2014-06-05

US20140155419A1

Chemistry; metallurgy

COMPOUNDS AND METHODS

#36 | 2014-06-05

US20140155381A1

Chemistry; metallurgy

COMPOUNDS AND METHODS

#37 | 2013-11-28

US20130317031A1

Chemistry; metallurgy

Nuclear transport modulators and uses thereof

#38 | 2008-10-23

US20080262016A1

Chemistry; metallurgy

ISOQUINOLINE DERIVATIVES AND METHODS OF USE THEREOF

#39 | 2008-06-24

US10369563

Cytotoxic agents containing novel potent taxanes and their therapeutic use

#40 | 2007-11-22

US20070270482A1

Chemistry; metallurgy

Cytotoxic agents comprising new C-2 modified taxanes

#41 | 2006-08-10

US20060178427A1

Chemistry; metallurgy

Cytotoxic agents comprising new taxanes

#42 | 2005-11-17

US20050256323A1

Chemistry; metallurgy

Facile method for synthesizing baccatin III compounds

#43 | 2005-10-13

US20050228007A1

Human necessities

Isoquinoline derivatives and methods of use thereof

#44 | 2005-04-21

US20050085513A1

Chemistry; metallurgy

Cytotoxic agents containing novel potent taxanes and their therapeutic use

#45 | 2005-02-03

US20050026997A1

Chemistry; metallurgy

Cytotoxic agents containing novel potent taxanes and their therapeutic use

InventorID:

549097 ⎘